Malignant Biliary Tract Neoplasm — Trials

Malignant Biliary Tract Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,282 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 367
Recruiting: 209
Ph III recruiting: 19
Growth YoY: +15.9%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (152)

clinicaltrialsPublishedShowing 851–900 of 1,282 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04946773	Deep Liver Phenotyping and Immunology Study(DELPHI)	recruiting	—	100	University of OxfordOTHER	1	Apr 6, 2022	clinicaltrials
NCT05019677	GP Chemotherapy in Combination With Tislelizumab and Ociperlimab as First-line Treatment in Advanced BTC	withdrawn	Phase 2	0	Fudan UniversityOTHER	1	Apr 4, 2022	clinicaltrials